高级检索
当前位置: 首页 > 详情页

Pathogenic role of the vitreous in angle-closure glaucoma with autosomal recessive bestrophinopathy: a case report

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Beijing Tongren Eye Center,Beijing Tongren Hospital,Beijing Institute of Ophthalmology,Capital Medical University,Beijing 100730,China. [2]Department of Ophthalmology,University of California,San Francisco School of Medicine,San Francisco,CA,USA. 3Beijing Tongren Hospital,1 Dongjiaominxiang Street,Dongcheng District,Beijing 100730,China.
出处:
ISSN:

关键词: Autosomal recessive bestrophinopathy Angle closure glaucoma Small dose transscleral cyclophotocoagulation Vitreous liquefaction

摘要:
Background Autosomal recessive bestrophinopathy (ARB) is caused by homozygous or compound heterozygous mutations in theBEST1gene and always accompanied with refractory angle-closure glaucoma (ACG). The exact mechanism for the pan-ocular abnormalities in ARB is still unknown and the management of ACG in these cases is challenging. Case presentation A 26-year-old patient with a novel autosomal-recessively inherited c.1 A > G variant inBEST1diagnosed as ARB and ACG, presented as widespread vitelliform deposits in the posterior pole, retinoschisis in the macula, vitreoretinal interface abnormalities, shallow anterior chamber depth (ACD) and angle closure with uncontrolled intraocular pressure (IOP). Combined phacoemulsification, intraocular lens implantation and goniosynechialysis did not improve any clinical presentation. However, low dose transscleral cyclophotocoagulation with subsequent vitreous liquefaction effectively lowered IOP, deepened ACD, and rehabilitated retinoschisis in both eyes. Conclusions This case implied vitreous condition may play a pathogenic role in formation of retinoschisis and ACG in the patients with ARB. Treatments that induce vitreous liquefaction could be used to treat young ACG patients with ARB or other kinds of ACG to avoid vision-threatening post-operative complications.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2019]版:
大类 | 4 区 医学
小类 | 4 区 眼科学
最新[2023]版:
大类 | 4 区 医学
小类 | 3 区 眼科学
JCR分区:
出版当年[2018]版:
Q3 OPHTHALMOLOGY
最新[2023]版:
Q3 OPHTHALMOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2018版] 出版当年五年平均 出版前一年[2017版] 出版后一年[2019版]

第一作者:
第一作者机构: [1]Beijing Tongren Eye Center,Beijing Tongren Hospital,Beijing Institute of Ophthalmology,Capital Medical University,Beijing 100730,China.
共同第一作者:
通讯作者:
通讯机构: [1]Beijing Tongren Eye Center,Beijing Tongren Hospital,Beijing Institute of Ophthalmology,Capital Medical University,Beijing 100730,China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:21193 今日访问量:0 总访问量:1219 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)